ASCO 2019: Novel targeted-antibody treatment produced responses in nearly half of patients with advanced urothelial cancer
A single arm, phase II clinical trial of 125 patients showed treatment with enfortumab vedotin…
Browsing: GU Cancers
Lifting the lid on bladder cancer support
Bladder cancer is a painful and sometimes life-threatening condition that patients can find difficult to…
Ipilimumab-heavy immunotherapy combination in metastatic bladder cancer
An immunotherapy combination with a higher dose of ipilimumab produced a 38 percent overall response…
Pain management protocol sends 92% of cancer surgery patients home without opioids
A specialised pain management program for patients who underwent robotic surgery for urologic cancers resulted…
How genomics profiling can help identify the best treatment for bladder cancer
When it comes to cancer, one-size-does-not-fit-all. “One of the challenges that we have when taking…
Quitting smoking is associated with reduced risk of bladder cancer in postmenopausal women
A large study of postmenopausal women indicated that quitting cigarette smoking was associated with significantly…
Early menopause in smokers linked to bladder cancer
Research shows that experiencing menopause before the age of 45 is associated with a higher…
Mental health state associated with higher death rates for prostate and urological cancers
Patients with prostate, bladder or kidney cancers are at greater risk of dying if they…
Study finds way to potentially improve immunotherapy for cancer
A new study has identified a drug that potentially could make a common type of…
ASCO GU 2019: Pembrolizumab Plus Axitinib Extended Overall Survival and Progression-Free Survival Versus Current Standard Treatment for Advanced Kidney Cancer
Results from the randomized, phase III KEYNOTE-426 clinical trial show that first-line therapy with a…